Health Care: Drugs

OncoMed Pharmaceuticals Inc (OMED: NASDAQ)

$17.98 -0.1 | -0.55%
09/23/14 - 03:04 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -26.07M -22.24M -15.03M
Operating Gains/Losses 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00
(Increase) Decrease In Receivables 4.00M -4.02M 9.00M
(Increase) Decrease in Inventories 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00
(Decrease) Increase In Payables 4.86M -3.18M 1.32M
(Decrease) Increase In Other Current Liabilities 18.71M 0.00 0.00
(Increase) Decrease In Other Working Capital 139.92M -5.48M -9.14M
Other Non-Cash Items 2.03M 824.00K 857.00K
Net Cash From Continuing Operations 144.54M -33.34M -11.29M
Net Cash From Discontinued Operations 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 144.54M -33.34M -11.29M
Sale of Property, Plant & Equipment 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 75.30M 112.67M 113.53M
Purchases of Property, Plant & Equipment -557.00K -714.00K -2.25M
Acquisitions 0.00 0.00 0.00
Purchases of Short-Term Investments -132.54M -73.94M -103.88M
Other Cash from Investing Activities 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -57.79M 38.01M 7.41M
Issuance of Debt 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 250.00K 156.00K 22.00K
Repayment of Long-Term Debt 0.00 -346.00K -703.00K
Repurchase of Capital Stock 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00
Other Financing Charges, Net 105.67M 0.00 0.00
Net Cash From Financing Activities 105.92M -190.00K -681.00K
Effect of Exchange Rate Changes 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 192.67M 4.48M -4.56M

Partner Headlines for OMED

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter